Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine

NeuroReport

Volumn 7, Issue 2, 1996, Pages 627-631

  Shults, Clifford W ^a,b   Kimber, Teresa ^a   Martin, David ^c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMGEN INC   (United States)

Author keywords

6 hydroxydopamine; dopamine; glial cell line derived neurotrophic factor; neuroprotection; Parkinson's disease; striatum; substantia nigra

Indexed keywords

AMPHETAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOCYTOCHEMISTRY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0029963121     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199601310-00060     Document Type: Article

References (25)

1. Lin L-FH, Doherty DH, Lue JD et al. Science 260, 1130-1132 (1993).
2. Poulsen KT, Armanini MP, Klein RD et al. Neuron 13, 1245-1252 (1994).
3. Henderson CE, Phillips HS, Pollock RA et al. Science 266, 1062-1064 (1994).
4. Springer JE, Mu X, Bergmann LW et al. Exp Neurol 127, 167-170 (1994).
5. Yan Q, Matheson C and Lopez OT. Nature 373, 341-344 (1995).
6. Martin D, Miller G, Rosendahl M et al. Brain Res 683, 172-176 (1995).
7. Jenner P, Schapira AHV and Marsden CD. Neurology 42, 2241-2250 (1992).
8. Schapira AHV. Neuropathol Appl Neurobiol 21, 3-9 (1995).
9. Zigmond MJ and Stricker EM. Int Rev Neurobiol 31, 1-79 (1989).
10. Tomac A, Lindqvist E, Lin L-F et al. Nature 373, 335-339 (1995).
11. Hoffer BJ, Hoffman A, Bowenkamp K et al. Neurosci Lett 182, 107-111 (1994).
12. Bowenkamp KE, Hoffman AF, Gerhardt GA et al. J Comp Neurol 355, 479-489 (1995).
13. Kearns C and Gash DM. Brain Res 672, 104-111 (1995).
14. Beck KD, Valverde J, Alexi T et al Nature 373, 339-341 (1995).
15. Linder MD, Winn SE, Baetge E et al. Exp Neurol 132, 62-76 (1995).
16. Olson L, Backlund E-O, Ebendal T et al. Arch Neurol 48, 373-381 (1991).
17. Shults CW, Matthews RT, Altar CS et al. Exp Neurol 125, 183-194 (1994).
18. Shults CW, Kimber T and Altar CA. NeuroReport 6, 1109-1112 (1995).
19. Zetterström T, Herrera-Marschitz M and Ungerstedt U. Brain Res 376, 1-7 (1986).
20. Dunnett SB, Bjorklund A, Schmidt RH ef al. Acta Physiol Scand Suppl 522, 29-37 (1983).
21. Hudson J, Granholm A-C, Gerhardt GA et al. Brain Res Bull 36, 425-432 (1995).
22. Robertson GS and Robertson HA. J Neurosci 9, 3326-3331 (1989).
23. Yung KKL, Bolam JP, Smith AD et al. Neuroscience 65, 709-730 (1995).
24. Rothwell NJ and Hopkins SJ. Trends Neurosci 18, 130-136 (1995).
25. Logan A, Berry M, Gonzalez AM et al. Eur J Neurosci 6, 355-363 (1994).